EMMESSACommodity Chemicals
Emmessar Biotech & Nutrition Ltd — PE Ratio & Valuation Analysis
₹23.56
+0.17%
Current P/E69.37xPrice to earnings
Industry P/E20.98xSector average
4Y Avg P/E39.3x76.7% above avg
⚠️
230.6% Premium to Industry
EMMESSA P/E 69.37x vs sector avg 20.98x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.61 | ₹29 | 48.1x |
| 2024 | ₹1.48 | ₹45 | 30.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Emmessar Biotech & Nutrition Ltd Valuation
Emmessar Biotech & Nutrition Ltd (EMMESSA) currently trades at 69.37x earnings. The Commodity Chemicals sector average PE is 20.98x. EMMESSA commands a premium, reflecting high growth expectations. Historically, EMMESSA has traded at an average PE of 39.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
4.23%
Dividend Yield
0.00%
More on Emmessar Biotech & Nutrition Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.